PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm

CRISPR Advances Can Accelerate Biopharmaceutical Drug Discovery and Development

For several years, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been making waves in the scientific community. Its ability to precisely edit genes has been utilized for accelerating drug discovery and development. Not only is CRISPR proving useful as a tool for the discovery of new treatment targets and for the development of potential therapies but it is also playing a role in some of the actual therapies being developed. Dr Christopher Vakulskas at IDT explains why this is especially true with cell and gene therapies being investigated using a
combination of CRISPR and regenerative medicine techniques.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/11/CRISPR-Advances-Can-Accelerate-Biopharmaceutical-Drug.pdf” width=”100%” height=”900px” style=”border:0;”]

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC